ATLAS AI

DeepMind Genome Atlas Variant Effect Explorer

Predicting DNA mutation impacts, molecular consequences, and targeted drug pathways
Validated Presets:
Interactive DNA Sequence Pad BRCA1 / Genome Atlas Cluster 4

Select a position along the 25-base genomic window or inject a base-pair transition to trigger the AlphaGenome & AlphaMissense pattern matching engine.

Reading Frame: Exon 11 / Exonic Splicing Enhancer (ESE)
Chromosomal locus: chr17:43,044,295-43,044,320 (GRCh38/hg38)
Sequence window: 25-mer sliding region centered at codon
Consequence & Therapeutic Match DeepMind Atlas Inference
0.89
Pathogenicity Index (0.0 - 1.0)
Likely Pathogenic
AlphaMissense / AlphaGenome Concordance
Transcriptional Disruption Index 89%
Splicing Motif Conservation Loss 92%
Predicted Phenotype
Exon Splicing Disruption & Transcriptional Suppression
Molecular Consequence
Premature Termination / Truncation
Chromatin Accessibility
-3.42 log2FC (Closed State)
Atlas Validation Cohort
ClinVar (P) / AlphaGenome Catalog
Primary Therapeutic Pathway Candidate
PARP Inhibitor + Targeted Genomic Correction
Synthetic lethality strategy targeting homologous recombination deficiency (Olaparib / Talazoparib pathway).
Active Genomic Research Summary (Durable Artifact)

Scientific Provenance & Discovered Knowledge

Reporting source: The Verge on DeepMind's AI models (including AlphaGenome & AlphaMissense) learning patterns between DNA variation and human biology. The AlphaGenome Atlas catalogues molecular impacts across both coding (2%) and non-coding (98%) regions of human DNA, estimating gene regulation, transcript stability, and therapeutic targets.

Evidence updated September 2026. This tool provides predictive simulation for academic and educational modeling.

Super generates helpful tools and automates fact-checking across the internet proactively. If you enjoyed this tool, build your own with Super and share it with a friend.